Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Transdermal Patch Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Transdermal Patch Market Status and Forecast (2016-2027)
      • 1.3.2 Global Transdermal Patch Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Transdermal Patch Supply by Company

    • 2.1 Global Transdermal Patch Sales Volume by Company
    • 2.2 Global Transdermal Patch Sales Value by Company
    • 2.3 Global Transdermal Patch Price by Company
    • 2.4 Transdermal Patch Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Transdermal Patch Market Status by Category

    • 3.1 Transdermal Patch Category Introduction
      • 3.1.1 Methyl Salicylate-based Patch
      • 3.1.2 Rivastigmine Transdermal Patch
      • 3.1.3 Fentanyl Transdermal Patch
      • 3.1.4 Lidocaine Patch
      • 3.1.5 Diclofenac Patch
      • 3.1.6 Nicotine Transdermal Patch
      • 3.1.7 Others
    • 3.2 Global Transdermal Patch Market by Category
      • 3.2.1 Global Transdermal Patch Sales Volume by Category (2016-2021)
      • 3.2.2 Global Transdermal Patch Sales Value by Category (2016-2021)
      • 3.2.3 Global Transdermal Patch Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Transdermal Patch Market Status by End User/Segment

    • 4.1 Transdermal Patch Segment by End User/Segment
      • 4.1.1 Rx Channel
      • 4.1.2 OTC Channel
    • 4.2 Global Transdermal Patch Market by End User/Segment
      • 4.2.1 Global Transdermal Patch Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Transdermal Patch Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Transdermal Patch Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Transdermal Patch Market Status by Region

    • 5.1 Global Transdermal Patch Market by Region
      • 5.1.1 Global Transdermal Patch Sales Volume by Region
      • 5.1.2 Global Transdermal Patch Sales Value by Region
    • 5.2 North America Transdermal Patch Market Status
    • 5.3 Europe Transdermal Patch Market Status
    • 5.4 Asia Pacific Transdermal Patch Market Status
    • 5.5 Central & South America Transdermal Patch Market Status
    • 5.6 Middle East & Africa Transdermal Patch Market Status

    6 North America Transdermal Patch Market Status

    • 6.1 North America Transdermal Patch Market by Country
      • 6.1.1 North America Transdermal Patch Sales Volume by Country (2016-2021)
      • 6.1.2 North America Transdermal Patch Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Transdermal Patch Market Status

    • 7.1 Europe Transdermal Patch Market by Country
      • 7.1.1 Europe Transdermal Patch Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Transdermal Patch Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Transdermal Patch Market Status

    • 8.1 Asia Pacific Transdermal Patch Market by Country
      • 8.1.1 Asia Pacific Transdermal Patch Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Transdermal Patch Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Transdermal Patch Market Status

    • 9.1 Central & South America Transdermal Patch Market by Country
      • 9.1.1 Central & South America Transdermal Patch Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Transdermal Patch Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Transdermal Patch Market Status

    • 10.1 Middle East & Africa Transdermal Patch Market by Country
      • 10.1.1 Middle East & Africa Transdermal Patch Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Transdermal Patch Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Transdermal Patch Distributors
    • 11.3 Transdermal Patch Buyers

    12 Global Transdermal Patch Market Forecast by Category and by End User/Segment

    • 12.1 Global Transdermal Patch Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Transdermal Patch Forecast by Category
      • 12.2.1 Global Transdermal Patch Sales Volume Forecast by Category
      • 12.2.2 Global Transdermal Patch Sales Value Forecast by Category
      • 12.2.3 Global Transdermal Patch Price Forecast by Category
    • 12.3 Global Transdermal Patch Forecast by End User/Segment
      • 12.3.1 Global Transdermal Patch Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Transdermal Patch Sales Value Forecast by End User/Segment
      • 12.3.3 Global Transdermal Patch Price Forecast by End User/Segment

    13 Global Transdermal Patch Market Forecast by Region/Country

    • 13.1 Global Transdermal Patch Market Forecast by Region (2022-2027)
      • 13.1.1 Global Transdermal Patch Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Transdermal Patch Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Hisamitsu Pharmaceutical
      • 14.1.1 Company Information
      • 14.1.2 Transdermal Patch Product Introduction
      • 14.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Johnson & Johnson
      • 14.2.1 Company Information
      • 14.2.2 Transdermal Patch Product Introduction
      • 14.2.3 Johnson & Johnson Transdermal Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Luye Pharma Group
      • 14.3.1 Company Information
      • 14.3.2 Transdermal Patch Product Introduction
      • 14.3.3 Luye Pharma Group Transdermal Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Endo International
      • 14.4.1 Company Information
      • 14.4.2 Transdermal Patch Product Introduction
      • 14.4.3 Endo International Transdermal Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 IBSA Group
      • 14.5.1 Company Information
      • 14.5.2 Transdermal Patch Product Introduction
      • 14.5.3 IBSA Group Transdermal Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Mundipharma
      • 14.6.1 Company Information
      • 14.6.2 Transdermal Patch Product Introduction
      • 14.6.3 Mundipharma Transdermal Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Pfizer
      • 14.7.1 Company Information
      • 14.7.2 Transdermal Patch Product Introduction
      • 14.7.3 Pfizer Transdermal Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Dr Reddy’s Laboratories
      • 14.8.1 Company Information
      • 14.8.2 Transdermal Patch Product Introduction
      • 14.8.3 Dr Reddy’s Laboratories Transdermal Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 GSK
      • 14.9.1 Company Information
      • 14.9.2 Transdermal Patch Product Introduction
      • 14.9.3 GSK Transdermal Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Novartis
      • 14.10.1 Company Information
      • 14.10.2 Transdermal Patch Product Introduction
      • 14.10.3 Novartis Transdermal Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Mylan
    • 14.12 Teva Pharmaceutical
    • 14.13 Chattem
    • 14.14 Beijing Tide Pharmaceutical
    • 14.15 Grünenthal
    • 14.16 Nitto Denko
    • 14.17 UCB Pharma
    • 14.18 Bayer

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Transdermal Patch market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Transdermal Patch market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Methyl Salicylate-based Patch
    Rivastigmine Transdermal Patch
    Fentanyl Transdermal Patch
    Lidocaine Patch
    Diclofenac Patch
    Nicotine Transdermal Patch
    Others

    Segmented by End User/Segment
    Rx Channel
    OTC Channel

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    Hisamitsu Pharmaceutical
    Johnson & Johnson
    Luye Pharma Group
    Endo International
    IBSA Group
    Mundipharma
    Pfizer
    Dr Reddy’s Laboratories
    GSK
    Novartis
    Mylan
    Teva Pharmaceutical
    Chattem
    Beijing Tide Pharmaceutical
    Grünenthal
    Nitto Denko
    UCB Pharma
    Bayer
    Buy now